Natural killer cell therapy for recurrent glioblastoma
Part of Cancer clinical trials.
This trial tests a treatment using your own immune cells, called natural killer cells, to fight a type of brain tumor called glioblastoma that has come back after standard treatment. The goal is to see if this therapy is safe and effective in slowing or stopping tumor growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 69 years old.
- You have been diagnosed with glioblastoma (a type of brain tumor) and have completed the standard first treatment (surgery, radiation, and chemotherapy).
- Your tumor has come back for the first time after completing standard treatment.
- You have not received any other cancer treatment for this recurrence, except possibly surgery.
- You are generally well enough to care for yourself (performance status score of 60 or higher on the Karnofsky scale).
- Your blood counts and liver and kidney function are within acceptable levels, and you have suitable veins for apheresis (a procedure to collect your white blood cells).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests engineered immune cells (called NK cells) that are designed to fight glioblastoma, a deadly brain cancer. The cells are injected directly into the tumor and may help patients whose cancer has come back after standard treatment.
This trial tests a new treatment using engineered immune cells (CAR-NK cells) that target two markers found on glioblastoma tumors. The treatment is given directly into the brain to fight tumors that have come back after standard therapy.
This trial tests a new treatment using your own immune cells that are genetically modified to find and attack brain tumor cells. It is for people with a type of brain cancer that has come back after standard therapy.
This early-phase trial studies a personalized immune-cell treatment (CAR-T) for glioblastoma that has come back. It aims to shrink or control the regrowing brain tumor by using your own immune cells after processing them in a lab.
This trial tests a new treatment using donated natural killer (NK) cells injected into the body to fight high-grade brain tumors. It might help people with certain types of aggressive gliomas that are newly diagnosed.
This trial tests a new type of immune cell therapy (NK cells) for patients with malignant brain tumors that have come back or worsened despite previous treatment. The goal is to see if these specially prepared immune cells can help fight the cancer.
Hear when a new Recurrent Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.